25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial

التفاصيل البيبلوغرافية
العنوان: 25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial
المؤلفون: Matthias Augustin, Michael Witte, Alexa B. Kimball, Claudia Rodriguez Capriles, Andrew Blauvelt, Angelina Sontag, Bruce Strober, Olawale Osuntokun, Vipin Arora, Yukari Okubo
المصدر: Journal of the American Academy of Dermatology. 85:AB64
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, Randomized controlled trial, business.industry, law, Internal medicine, Psoriasis, medicine, Dermatology, medicine.disease, business, law.invention
تدمد: 0190-9622
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8f77784b90700df942fdc2a63bf14df3
https://doi.org/10.1016/j.jaad.2021.06.283
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........8f77784b90700df942fdc2a63bf14df3
قاعدة البيانات: OpenAIRE